Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer
Clinical Breast Cancer · 2023
DOI: 10.1016/j.clbc.2023.06.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2023. Verfasst von Seung Taek Lim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Yonsei University Wonju College of Medicine, Wonju, Korea. Hauptthemen laut MEDLINE: Receptors, Estrogen, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUNDS: Tumor vascularity plays a fundamental role in cancer progression, including breast cancer. This study aimed to elucidate tumor vascularity and its impact on patient survival in the context of breast cancer subtypes using Hounsfield units (HU) on contrast-enhanced computed tomography (CT). MATERIALS AND METHODS: Patients with early-stage breast cancer who completed planned treatment between 2003 and 2013 were retrospectively assessed. RESULTS: The final cohort comprised 440 patients. Of the 440 patients, 262 had estrogen receptor (ER)-positive disease and 119 had human epidermal growth factor receptor 2 (HER2)-overexpressing disease. The tumor-to-aorta ratio of Hounsfield units (TAR) was related to significantly worse recurrence-free interval (RFI) (P 0.33 for RFI and > 0.35 for OS than their counterparts. In the subgroup analysis, the survival disadvantage was limited only to patients with ER-positive and HER2-negative disease (P < .001 for both RFI and OS). CONCLUSION: This study showed that TAR, which reflects tumor vascularity, was significantly related to patients' RFI and OS, suggesting its capacity as a feasible biomarker. This study also showed that TAR was associated with the survival in patients with ER-positive and HER2-negative disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Yonsei University Wonju College of Medicine, Wonju, Korea.
- Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea.
- Department of Radiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea.
- Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea. Electronic address: airihan@yonsei.ac.kr.
Zitieren
APA
Lim, S. T., Choi, H. S., Kim, K., Hahn, S., Cho, I. J., Noh, H., Lee, J. I., & Han, A. (2023). Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2023.06.012
Vancouver
Lim ST, Choi HS, Kim K, Hahn S, Cho IJ, Noh H, et al. Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer. Clinical Breast Cancer. 2023. doi:10.1016/j.clbc.2023.06.012
BibTeX
@article{Lim2023,
author = {Lim, Seung Taek and Choi, Hyang Suk and Kim, Kwangmin and Hahn, Seok and Cho, In-Jeong and Noh, Hany and Lee, Jong-In and Han, Airi},
title = {Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer},
journal = {Clinical Breast Cancer},
year = {2023},
doi = {10.1016/j.clbc.2023.06.012}
}
EUVIMED